• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

    3/18/25 4:47:00 PM ET
    $CMBM
    $DOMO
    $EVH
    $MDRX
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $CMBM alert in real time by email

    Appoints Jonathan Sacks and Bruce Felt to the Board

    Lou Silverman to Succeed Greg Garrison as Chairman

    Veradigm Inc. (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the "Board") appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of the Board upon Mr. Garrison's retirement. Further, independent director Vinit Asar has been named Chair of the Nominating and Governance Committee.

    Mr. Sacks is a Partner at Stonehill Capital Management LLC ("Stonehill"), where he has been for over 20 years, and brings deep financial expertise and strategic insight to the Board. At Stonehill he has led and managed debt and equity investments across many industries including healthcare and software. While at Stonehill, Mr. Sacks has had extensive experience investing in companies undergoing complex transitions such as accounting challenges, delistings, and capital structure changes. Stonehill, through funds it manages on behalf of institutional investors and others, is Veradigm's largest shareholder.

    Mr. Felt has served as Chief Financial Officer (CFO) at several public companies in the technology space, including most recently at Domo (NASDAQ:DOMO), a cloud software company that specializes in business intelligence tools and data visualization. During his nearly nine-year tenure as CFO, Mr. Felt oversaw the scaling of Domo's enterprise cloud business and helped take the company public in 2018. Prior to Domo, he served as CFO at SAP SuccessFactors (NASDAQ:SFSF) and FullTime Software (NASDAQ:FTSW), overseeing the sales of both companies. He currently serves on the board of directors of Cambium Networks (NASDAQ:CMBM), including as Audit Committee Chair. Mr. Felt also previously served as lead independent director and Audit Committee Chair at Evolent Health (NYSE:EVH).

    "Veradigm remains focused on strong governance and strategic oversight as we continue to drive innovation and seek to maximize value for our stockholders," said Mr. Garrison. "On behalf of the entire Board, I am pleased to welcome Jonathan and Bruce, who bring deep leadership, financial stewardship, and technology experience to the Board. Additionally, we are confident that with Bruce's extensive financial and accounting background, he is highly qualified to serve as Audit Committee Chair."

    Mr. Garrison continued "I am very pleased that Lou Silverman has agreed to assume the role of Chairman upon my departure. With Lou's 30 years of leadership experience in health information technology and technology-enabled healthcare services, the Board is confident in his ability to lead the Board as it oversees Veradigm's next phase."

    "It will be an honor to serve as Veradigm's Chairman of the Board as the Company navigates this important time," said Mr. Silverman. "I want to thank Greg for his leadership and vision, and I look forward to working closely with the rest of the Board as we focus on our priorities: remediating our material weaknesses and other internal control deficiencies, becoming current in our financial reporting, executing our growth strategy, and relisting our common stock."

    The appointments of Messrs. Felt and Sacks to the Board satisfy Veradigm's obligations under the February 2025 Cooperation Agreement with Kent Lake PR LLC.

    About Veradigm®

    Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

    © 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250318997143/en/

    Investors:

    Jenny Gelinas

    312-506-1237

    [email protected]

    Media:

    Amanda Cohen

    412-919-2417

    [email protected]

    Get the next $CMBM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMBM
    $DOMO
    $EVH
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    Domo Inc.
    $DOMO
    8/26/2025$21.00Hold → Buy
    TD Cowen
    Domo Inc.
    $DOMO
    7/18/2025$19.00Overweight
    Stephens
    Domo Inc.
    $DOMO
    3/7/2025$9.00 → $8.00Neutral
    DA Davidson
    Domo Inc.
    $DOMO
    2/11/2025$11.00Overweight
    Cantor Fitzgerald
    Evolent Health Inc
    $EVH
    1/10/2025$15.00Buy
    Needham
    Evolent Health Inc
    $EVH
    12/3/2024$36.00 → $29.00Buy
    BTIG Research
    Evolent Health Inc
    $EVH
    11/8/2024$38.00 → $16.00Overweight → Equal-Weight
    Stephens
    Evolent Health Inc
    $EVH
    10/11/2024$35.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Domo upgraded by TD Cowen with a new price target

    TD Cowen upgraded Domo from Hold to Buy and set a new price target of $21.00

    8/26/25 8:09:00 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Stephens initiated coverage on Domo with a new price target

    Stephens initiated coverage of Domo with a rating of Overweight and set a new price target of $19.00

    7/18/25 8:14:38 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    DA Davidson resumed coverage on Domo with a new price target

    DA Davidson resumed coverage of Domo with a rating of Neutral and set a new price target of $8.00 from $9.00 previously

    3/7/25 7:23:12 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    SEC Filings

    View All

    Evolent Health Inc filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Evolent Health, Inc. (0001628908) (Filer)

    9/23/25 4:13:27 PM ET
    $EVH
    Other Consumer Services
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Domo Inc.

    SCHEDULE 13G - DOMO, INC. (0001505952) (Subject)

    9/17/25 6:10:48 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Domo Inc.

    10-Q - DOMO, INC. (0001505952) (Filer)

    9/4/25 7:35:33 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Founder and CEO James Joshua G bought $165,897 worth of Class B Common Stock (13,025 units at $12.74), increasing direct ownership by 1% to 1,079,972 units (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    6/23/25 9:37:55 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Director Daniel Daniel David Iii bought $772,452 worth of Class B Common Stock (120,000 units at $6.44) (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    4/4/25 9:37:24 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Founder and CEO James Joshua G bought $502,172 worth of Class B Common Stock (77,300 units at $6.50) (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    4/4/25 9:36:07 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    Cambium Networks Expands ONE Network Portfolio with Wireless and Wired Access Solutions to Power Next-Generation Connectivity

    New multi-gigabit Wi-Fi 7 and switch solutions are built to adapt to the evolving needs of AI-powered enterprise networks in a cost-effective way HOFFMAN ESTATES, Ill., Sept. 24, 2025 /PRNewswire/ -- Cambium Networks (NASDAQ:CMBM), a leading global provider of networking solutions, today announced a powerful expansion to its ONE Network solutions with the introduction of new multi-gigabit Wi-Fi 7 access points and cnMatrix™ switches. Purpose-built to meet the performance and security needs of networks into the future, these offerings enable organizations to build sustainable, forward-looking networks, including service providers, hospitality properties, educational institutions, public venu

    9/24/25 6:00:00 AM ET
    $CMBM
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

    Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path.Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to Evolent's free cash flow by more than $7 million per year.Evolent reiterates outlook for Q3 2025 and full year 2025 for Revenue and Adjusted EBITDA, excluding the effect of the transaction.WASHINGTON, Sept. 23, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that it has agreed to sell its value-based primary care business, Evolent Care Partners ("ECP"), to Privia Health Grou

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel Daniel David Iii was granted 124 units of Class B Common Stock and disposed of 507,500 units of Class B Common Stock (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    9/24/25 6:40:34 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Director Jolley David R covered exercise/tax liability with 5,330 units of Class B Common Stock, decreasing direct ownership by 2% to 248,021 units (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    9/23/25 6:06:42 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Maughan Mark covered exercise/tax liability with 7,178 units of Class B Common Stock, decreasing direct ownership by 3% to 241,623 units (SEC Form 4)

    4 - DOMO, INC. (0001505952) (Issuer)

    9/23/25 6:05:48 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Financials

    Live finance-specific insights

    View All

    Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

    Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path.Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to Evolent's free cash flow by more than $7 million per year.Evolent reiterates outlook for Q3 2025 and full year 2025 for Revenue and Adjusted EBITDA, excluding the effect of the transaction.WASHINGTON, Sept. 23, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced that it has agreed to sell its value-based primary care business, Evolent Care Partners ("ECP"), to Privia Health Grou

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Domo Announces Second Quarter Fiscal 2026 Financial Results

    Domo, Inc. (NASDAQ:DOMO) today announced results for its fiscal second quarter ended July 31, 2025. Fiscal Second Quarter Results Total revenue was $79.7 million Subscription revenue was $72.7 million Billings were $70.3 million Subscription Remaining Performance Obligations (RPO) was $409.8 million as of July 31, 2025, an increase of 19% year over year Current subscription RPO was $220.2 million as of July 31, 2025, an increase of 4% year over year Net cash provided by operating activities was $3.4 million, an increase of 155% year over year Adjusted free cash flow was $1.4 million, an increase of 125% year over year GAAP operating margin was negative 9%, an incre

    8/27/25 4:05:00 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Veradigm Inc.

    SC 13G - Veradigm Inc. (0001124804) (Subject)

    11/14/24 4:05:58 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/14/24 1:11:13 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Domo Inc.

    SC 13G/A - DOMO, INC. (0001505952) (Subject)

    11/14/24 12:25:56 PM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $CMBM
    $DOMO
    $EVH
    $MDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health

    ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE:EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid. Privia Health will pay $100 million in cash at closing and up to an additional $13 million su

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

    Appoints Jonathan Sacks and Bruce Felt to the Board Lou Silverman to Succeed Greg Garrison as Chairman Veradigm Inc. (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the "Board") appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of the Board upon Mr. Garrison's retirement. Further, independent director Vinit Asar has been named Chair of the Nominating and Go

    3/18/25 4:47:00 PM ET
    $CMBM
    $DOMO
    $EVH
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Computer Software: Prepackaged Software
    Other Consumer Services